Live Quote · NASDAQITCIHealthcare· Drug Manufacturers - Specialty & Generic

Intra-Cellular Therapies, Inc.

$131.87
MKT CAP $14.05B
50%
Bullish
TickerSpark Score
62/100
▌ Mixed
27
Valuation
40
Profitability
100
Growth
80
Health

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ITCI research report →

Analyst Price Target
$98.50-25.3% vs. today

Range $70 – $132

Analyst RatingBuy
14 Buy9 Hold0 Sell

Price Chart

+97.80% · this period
$131.92$98.34$64.76Apr 02Oct 01Apr 02